Industry
Biotechnology
Topic
IPOs
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
IPOs in Biotechnology
... SAN DIEGO, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. ("Bionano"), a life sciences instrumentation company that develops and markets Saphyr, ...
... Fall and Winter:BioRestorative Therapies, Inc.(OTC: BRTX),CV Sciences, Inc.(OTC: CVSI),22ndCentury Group, Inc.(NYSE: XXII),Tilray, Inc.(NASDAQ: TLRY),andAphria Inc.(OTC: APHQF). BioRestorative Therapies, Inc.(OTCQB: BRTX) Market Cap: $16.09M Share Price: ...
... Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today financial results for ...
... ROCHESTER, N.Y., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Vaccinex), a clinical-stage biotechnology company engaged in the discovery and development of ...
... YONKERS, N.Y., July 26, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a biotechnology company focused on the discovery and development of protein ...
... commenced an underwritten public offering of $400 million of its common stock. bluebird bio also intends to grant the underwriters a 30-day option to purchase ...
... WOBURN, Mass., July 19, 2018 (GLOBE NEWSWIRE) -- Replimune Group, Inc., a biotechnology company developing oncolytic immunotherapies derived from its Immulytic„¢ platform, ...
... CAMBRIDGE, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company pioneering the development of a new class ...
... Myovant Sciences Ltd. (NYSE: MYOV) ("Myovant"), a clinical-stage biopharmaceutical company focused on developing and commercializing ...
... Rochester, New York-based antibody developer Vaccinex hopes to raise $46 million in an IPO, listing on the Nasdaq ...
Subscribe now for full coverage on IPOs in Biotechnology
Start My Free Trial